Production of 8′-Halogenated and 8′-Unsubstituted Novobiocin Derivatives in Genetically Engineered Streptomyces coelicolor Strains

This publication has 42 references indexed in Scilit:

• Para-position derivatives of fungal anthelmintic cyclodepsipeptides engineered with Streptomyces venezuelae antibiotic biosynthetic genes
  Nature Biotechnology, 2004
• Where will new antibiotics come from?
  Nature Reviews Microbiology, 2003
• Natural Products as Sources of New Drugs over the Period 1981−2002
  Journal of Natural Products, 2003
• Metabolic Fluxes and Metabolic Engineering
  Metabolic Engineering, 1999
• A prospective crossover randomized trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with interleukin-2
  Cancer, 1998
• DNA gyrase as a drug target
  Trends in Microbiology, 1997
• Molecular mechanisms of durg inhibition of DNA gyrase
  BioEssays, 1996
• Antibiotics and prevention of microbial colonization of catheters
  Antimicrobial Agents and Chemotherapy, 1995
• The interaction between coumarin drugs and DNA gyrase
  Molecular Microbiology, 1993
• Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome
  Antimicrobial Agents and Chemotherapy, 1993